PGLYRP2

peptidoglycan recognition protein 2, the group of Peptidoglycan recognition proteins

Basic information

Region (hg38): 19:15468645-15498956

Links

ENSG00000161031NCBI:114770OMIM:608199HGNC:30013Uniprot:Q96PD5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PGLYRP2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PGLYRP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
21
clinvar
2
clinvar
1
clinvar
24
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 21 2 1

Variants in PGLYRP2

This is a list of pathogenic ClinVar variants found in the PGLYRP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-15468716-T-C not specified Uncertain significance (Aug 23, 2021)2246594
19-15468726-A-C not specified Likely benign (Aug 16, 2021)2226471
19-15469700-G-T not specified Uncertain significance (Dec 14, 2023)3211818
19-15469781-T-C not specified Uncertain significance (Oct 04, 2022)2363839
19-15469826-C-T not specified Uncertain significance (Nov 01, 2022)2327933
19-15469873-C-T not specified Uncertain significance (Aug 22, 2022)2308805
19-15471938-A-C not specified Uncertain significance (Nov 30, 2022)2330012
19-15471996-A-G not specified Uncertain significance (May 24, 2024)3305993
19-15472034-A-G not specified Uncertain significance (Jan 18, 2022)2233956
19-15475615-T-C not specified Uncertain significance (Oct 24, 2023)3211817
19-15475645-A-C not specified Uncertain significance (Jul 25, 2023)2613955
19-15475714-C-T not specified Uncertain significance (Jan 09, 2024)3211823
19-15475793-G-A not specified Uncertain significance (Apr 13, 2022)2341969
19-15475903-C-T not specified Uncertain significance (Jun 16, 2024)3305991
19-15475969-C-A Benign (Mar 29, 2018)720778
19-15475972-C-G not specified Uncertain significance (Oct 27, 2021)2288335
19-15475996-C-T not specified Uncertain significance (Apr 12, 2022)2218542
19-15476075-C-T not specified Uncertain significance (May 26, 2022)2361399
19-15476177-C-T not specified Uncertain significance (May 23, 2023)2549990
19-15476231-C-A not specified Uncertain significance (Dec 20, 2023)3211821
19-15476240-T-C not specified Uncertain significance (Nov 06, 2023)3211820
19-15476266-C-T not specified Likely benign (Feb 16, 2023)2472036
19-15476267-G-T not specified Uncertain significance (May 13, 2024)3305992
19-15476345-C-A not specified Uncertain significance (Jun 12, 2023)2509292
19-15476345-C-G not specified Uncertain significance (Feb 15, 2023)2484687

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PGLYRP2protein_codingprotein_codingENST00000340880 530312
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.68e-110.1461256821651257480.000262
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.072763310.8350.00001873614
Missense in Polyphen74104.60.707491164
Synonymous1.901151440.7980.000008181305
Loss of Function0.6031821.00.8580.00000126198

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006660.000666
Ashkenazi Jewish0.00009930.0000992
East Asian0.0002180.000217
Finnish0.00004620.0000462
European (Non-Finnish)0.0001850.000185
Middle Eastern0.0002180.000217
South Asian0.0007890.000752
Other0.0003270.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: May play a scavenger role by digesting biologically active peptidoglycan (PGN) into biologically inactive fragments. Has no direct bacteriolytic activity. {ECO:0000269|PubMed:14506276}.;
Pathway
Antimicrobial peptides;Innate Immune System;Immune System (Consensus)

Recessive Scores

pRec
0.146

Intolerance Scores

loftool
0.841
rvis_EVS
1.47
rvis_percentile_EVS
95.25

Haploinsufficiency Scores

pHI
0.105
hipred
N
hipred_score
0.188
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.128

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pglyrp2
Phenotype
homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
peptide amidation;pattern recognition receptor signaling pathway;peptidoglycan catabolic process;detection of bacterium;antimicrobial humoral response;negative regulation of interferon-gamma production;negative regulation of natural killer cell differentiation involved in immune response;growth of symbiont in host;innate immune response;regulation of inflammatory response;defense response to Gram-positive bacterium
Cellular component
extracellular region;extracellular space;membrane;extracellular exosome
Molecular function
zinc ion binding;N-acetylmuramoyl-L-alanine amidase activity;peptidoglycan receptor activity;peptidoglycan binding